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Abstract
Introduction: Children exposed to secondhand smoke (SHS) are at increased risk of respiratory 
illnesses. We piloted a Smoke Free Intervention (SFI) and trial methods before investigating its 
effectiveness and cost-effectiveness in primary school children.
Methods: In a pilot cluster randomized controlled trial in Bangladesh, primary schools were 
allocated to usual education (control) or SFI, using minimization. Year-5 children were recruited. 
Masking treatment allocation was not possible. Delivered by schoolteachers, SFI consisted of 
two 45-min and four 15-min educational sessions. Our primary outcome was SHS exposure at 
two months post randomization, verified by children’s salivary cotinine. The trial is registered at 
ISRCTN.com; ISRCTN68690577.
Results: Between April 1, 2015 and June 30, 2015, we recruited 12 schools. Of the 484 children 
present in Year-5, 481 consented. Six schools were allocated to both SFI (n = 245) and to usual 
education only (n = 236). Of them, 450 children (SFI = 229; control = 221) who had cotinine levels 
indicative of SHS exposure were followed-up. All schools were retained, 91% children (208/229) 
in SFI and 88% (194/221) in the control arm completed primary outcome assessment. Their mean 
cotinine at the cluster level was 0.53 ng/ml (SD 0.36) in SFI and 1.84 ng/ml (SD 1.49) in the control 
arm—a mean difference of −1.31 ng/ml (95% CI = −2.86 to 0.24).
Conclusion: It was feasible to recruit, randomize, and retain primary schools and children in our 
trial. Our study, though not powered to detect differences in mean cotinine between the two arms, 
provides estimates to inform the likely effect size for future trials.
Implications: In countries with high smoking prevalence, children remain at risk of many condi-
tions due to secondhand smoke exposure. There is little empirical evidence on the effectiveness 
and cost-effectiveness of interventions that can reduce their exposure to secondhand smoke at 
homes. CLASS  II trial found that a school-based intervention (SFI) has the potential to reduce 
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children’s exposure to SHS—an approach that has been rarely used, but has considerable merit in 
school-based contexts. CLASS II trial provides key information to conduct a future definitive trial in 
this area of public health, which despite its importance has so far received little attention.
Introduction
The health consequences of children’s exposure to secondhand smoke 
(SHS) are serious and well established.1 SHS exposure impairs their lung 
development and causes immune dysregulation.2 Children are therefore 
at an increased risk of chest infections, tuberculosis (TB),3 and asthma.4 
Moreover, SHS exposure in children and adolescents leads to poor 
cognitive functions and academic achievements.5 Children exposed to 
smoking behaviors by their family members have an increased chance of 
taking up smoking.6 Unfortunately, 40% of children could be exposed 
to SHS worldwide amounting to a major public health threat.7
Signatory to the Framework Convention of Tobacco Control 
(FCTC), most countries have now banned smoking in indoor pub-
lic spaces and workplaces.8 Where enforced strictly, these bans have 
resulted in a significant reduction in SHS exposure and its associated 
morbidity and mortality.9 However, children are mostly exposed to 
SHS in their homes and cars;10 additional measures are therefore 
required to provide comprehensive protection from SHS exposure.
Bangladesh, among the first few signatories to FCTC, introduced 
smoke-free legislation in 2005–2006 and strengthened it further in 
2012 through a comprehensive smoking ban in most indoor public 
places, workplaces, and public transport.11 Despite this, the  2009 
Global Adult Tobacco Survey (GATS) suggested that 57% of chil-
dren (27.6 million) could be exposed to SHS in Bangladesh.12
There is little evidence on the effectiveness of interventions to 
protect children from SHS exposure. Two recent reviews remain 
inconclusive. A Cochrane review included 57 trials, many assessing 
the effect of parental education and counseling programs;13 a fur-
ther systematic review and meta-analysis, included 16 trials of inter-
ventions delivered by healthcare professionals who provide routine 
child healthcare, neither found a significant reduction in children’s 
SHS exposure.14 Another meta-analysis, which reported on the effect 
of interventions aimed at reducing SHS exposure in homes, found 
some improvements but recommended further research.15
In Bangladesh, we developed a school-based Smoke Free 
Intervention (SFI) to encourage children to negotiate smoking 
restrictions in their households. In a feasibility trial (CLASS I), we 
found that SFI was successful in implementing self-reported volun-
tary smoking restrictions and in reducing social visibility of smoking 
behavior (OR = 3.9, 95% CI = 2.0 to 7.5) at home.16 However, we 
did not demonstrate if this change translated in a reduction in SHS 
exposure in children (eg, reduction in cotinine levels) or in indoor air 
pollution (eg, reduction in PM2.5).
Our ultimate aim is to assess the effectiveness and cost-effectiveness 
of the SFI in children exposed to SHS. Prior to conducting a definitive 
trial to answer the above question, we sought preliminary evidence of 
effectiveness in this population and tested methods for recruitment, 
randomization, and outcomes measurement. We also explored accept-
ability and feasibility of delivering the SFI with teachers and head 
teachers. This is reported elsewhere (manuscript in preparation).
Methods
Study Design
CLASS II was a large, two-arm, pilot, cluster randomized controlled 
trial (RCT) with an embedded preliminary economic analysis. It 
was conducted in 12 schools in Dhaka Division, Bangladesh. The 
study received ethics approvals from Bangladesh Medical Research 
Council’s and the University of York’s ethics committees. A detailed 
trial protocol has previously been published.17
Participants
We recruited children from primary schools that followed national 
curricula, had Year-5 classes with >40 and <120 children/class, an 
associated secondary school, and a non-smoking policy on their 
premises. All schools situated within Mirpur and Savar (Dhaka) 
were contacted and those that responded positively within seven 
days were assessed for eligibility. All Year-5 children (expected age 
range = 10–12 years) who were self-reported non-smokers, were 
eligible to participate. We excluded children with serious mental 
and physical conditions, disabilities including learning difficul-
ties, and those showing severe behavioral problems. The schools 
provided a list of all eligible children who were then recruited 
after obtaining their written, informed, assent, and parental con-
sent on an opt-out basis.
Randomization
All participating schools were randomly allocated to two arms follow-
ing a computer-generated minimization sequence. Although schools 
in both arms received routine education as prescribed by the National 
Curriculum and Textbook, those in the intervention arm received SFI 
in addition. At the time of the CLASS  II trial, this curriculum and 
the textbooks contained no information on secondhand smoke and 
its associated harms. Minimization—a method of adaptive stratified 
sampling—was used to restrict randomization on school’s public/pri-
vate status and boys to girls’ ratio. The schools’ identification was 
concealed from the trial statistician, who generated the allocation 
sequence and assigned schools to the trial arms. Because of the nature 
of the intervention, it was not possible to mask the children, school-
teachers or researchers from the intervention allocation.
Procedures
Soon after obtaining consent, we carried out children’s baseline 
assessment. This contained a classroom-administered questionnaire 
that included socio-demographic  information and questions on 
smoking behavior, quality of life, and health service use and was 
completed by participating children. In addition, schoolteachers 
completed an Academic Performance Questionnaire (APQ)18 and 
a school absenteeism form. We also assessed children’s lung func-
tion tests and collected saliva (morning samples) for cotinine test. 
Children were also asked to complete a daily respiratory symptoms 
diary. After baseline data collection, schools were allocated to the 
two trial arms. Post allocation, children with salivary cotinine levels 
indicative of SHS exposure were followed-up at 2, 6, and 12 months. 
The follow-ups included all assessments except salivary cotinine lev-
els, which happened at 2-month follow-up only.
Intervention
SFI was a theory-based behavior change intervention19 developed by a 
multidisciplinary group in Bangladesh.16 SFI was delivered by Year-5 
schoolteachers who were provided the relevant resource materials 
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and training. The intervention was delivered to all children as a group 
in a classroom setting irrespective of their baseline cotinine levels. 
It consisted of two 45-min sessions delivered over two consecutive 
days. Each session included classroom presentations, quiz, interac-
tive games, storytelling, and role-play—utilizing vicarious learning 
techniques.16 The presentation, quiz, and games aimed to make chil-
dren aware of the harms of SHS and motivate them to achieve a 
smoke-free home. The storytelling and role-play activities focused on 
building children’s confidence in raising their concerns about SHS 
with their parents and enhance their negotiation skills. Although sto-
rytelling illustrated numerous challenges of discussing adults’ smok-
ing behavior within families, role-play allowed children to learn and 
practice relevant negotiating strategies. These were followed by four 
refresher sessions (15 min each) over the subsequent 4 weeks. These 
sessions reinforced learning by revising the salient points of the ini-
tial sessions and by encouraging children to share their experience of 
initiating relevant conversations within their families. Teachers also 
helped children to plan their next action. Children were also provided 
with take-home promise forms for families that provided graphic rep-
resentations of the hazards of SHS, pictorial guidance to help them 
make their homes smoke free, and a tear-off slip to commit to impos-
ing smoking restrictions at home. These restrictions extended to visi-
tors and cars too. Teachers were also trained to pick up any signs of 
distress among children as an untoward consequence of SFI.
Controls
Schools in the control arm did not receive any intervention but only 
study information.
Outcomes
The primary outcome was a change in children’s salivary cotinine—
a sensitive biochemical marker strongly associated with recent SHS 
exposure. Collected by keeping a sterile swab in the mouth for ap-
proximately 5 min and then transferring to a sterile plastic container, 
the saliva samples were analyzed using gas-liquid chromatography 
technique at ABS laboratories in the United Kingdom.
Our secondary outcomes included the frequency and severity 
of respiratory symptoms, lung function tests, self-reported smoking 
restrictions, health service use, quality of life, academic performance, 
and school absenteeism.
Furthermore, children kept a diary for 13 respiratory symptoms 
and recorded their severity on a four-point scale on a daily basis.20 
For upper respiratory tract symptoms, children reported on hav-
ing a runny nose or sneezing, blocked or stuffy nose, sore throat 
or hoarse voice, headaches or face aches, aches or pains elsewhere, 
and feeling chill, fever, or shivers. For lower respiratory symptoms, 
cough on waking, wheeze on waking, cough during the day, wheeze 
during the day, shortness of breath during the day, night cough, 
and wheeze or shortness of breath during the night, were included. 
Presence of at least four of these symptoms on any one day was 
considered a clinical episode. We estimated the proportion of chil-
dren with at least one clinical episode and mean clinical episodes 
per child. Children’s lung functions including forced vital cap-
acity (FVC), forced expiratory volume in the first second (FEV1), 
and peak expiratory flow (PEF) were measured using a handheld 
Micro1 spirometer as per Thoracic Society guidelines.21 In addition 
to absolute PEF, we estimated relative PEF as a proportion of the 
predicted PEF, based on age and sex.
Children reported on smoking restrictions and its social visibility 
at home. The questionnaire asked: (1) “Are people who live with you 
allowed to smoke?” (Anywhere inside your home/in some rooms in 
your home/ only in one room in your home/ only outside); (2) “Are 
people who visit your home allowed to smoke?” (Anywhere inside 
your home/in some rooms in your home/ only in one room in your 
home/ only outside); (3) “Are people who live with you allowed to 
smoke in front of children?” (Y/N); and (4) “Are people who visit 
your home allowed to smoke in front of children?” (Y/N). Variables 
on smoking restrictions for residents and visitors were later com-
bined to create a composite variable indicating “complete restric-
tion” if the responses were “only outside” for both variables, “no 
restriction” if the answer was “anywhere inside your home” for 
either of the two variables and “partial restriction” for all other 
combinations.
Children’s academic performance was assessed using the 
Academic Performance Questionnaire (APQ).18 The teachers 
reported on children’s reading, maths and writing performance 
as: (1) well above average; (2) at or somewhat above average; (3) 
somewhat below average; and (4) well below average. Schools also 
provided reports on children’s school absenteeism (number of days 
missed in the last month).
We also measured recruitment and attrition rates for clusters and 
participants including their reasons for ineligibility and non partici-
pation, the intra-cluster correlation coefficient (ICC) for the primary 
outcome, the costs associated with delivering SFI, and the time and 
resources required in measuring outcomes and the extent and type 
of missing data. The baseline questionnaire also collected data on 
other potential confounders including: age, gender, medical history, 
household amenities, family structure, co-habiting smokers—includ-
ing parents, pet ownership, overcrowding—number of rooms and 
residents, built environment, neighborhood (number of shops selling 
tobacco within 5 min of walking distance from home), presence of 
mould/moisture, and the type of fuel used for cooking in homes.
Statistical Analysis
We aimed to recruit at least 12 schools (clusters) and 360 children 
(participants), 30 per school, for this pilot RCT. Among these, we 
expected at least a third (120 children) to have a baseline salivary 
cotinine result indicative of recent SHS exposure. Based on our feasi-
bility study,16 we predicted retaining all 12 schools and at least 80% 
of all participants in the trial. We anticipated that a pilot trial that 
retains approximately 100 children was likely to provide robust esti-
mates of the effect size, recruitment and retention rates, and ICC 
ahead of a definitive trial.
We conducted a preliminary analysis summarizing: participant 
(individual and cluster) characteristics, recruitment attrition rates, 
effect size, and ICC. Although determining differences in the out-
comes between the two arms was not the purpose of this study, we 
summarized outcomes at both cluster and individual levels using 
an intention-to-treat principle (ITT) and estimated 95% confidence 
intervals (CIs) for any differences. We explored the likely difference 
in the cotinine levels at the first follow-up at the cluster level using 
two-sample t-test adjusted for unequal variance. Furthermore, we 
explored the likely effect size using individual level data adjusted for 
clustering and taking into account minimization variables. To this 
effect, we have used linear regression models with random intercepts 
to account for the clustering using maximum likelihood estima-
tion. We also report on the effect size when controlling for baseline 
cotinine levels and other demographic baseline variables. We also 
summarized all other secondary outcomes descriptively. All analyses 
were conducted using STATA v.14.22
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Preliminary Economic Analysis
We also assessed the feasibility of undertaking a full cost-effective-
ness analysis in future. We estimated the cost of delivering the SFI 
including the time and resources needed to deliver the intervention. 
Health service utilization was assessed by asking pre-tested ques-
tions23 on contacts with doctors/nurses, hospital admissions, phar-
macy visits, and antibiotic prescriptions. Quality of life was assessed 
using a short quality of life questionnaire for children EQ-5DY.24 We 
also audited data for completeness.
The trial is registered at ISRCTN.com and the number 
ISRCTN68690577.
Results
Between April 1, 2015 and June 30, 2015, we approached 25 schools 
and recruited 12 (Figure 1); seven declined to participate due to work-
load issues and six were ineligible: three schools did not follow govern-
ment-approved curriculum, one had a small class size, and two were 
not linked to secondary schools. Of 576 children studying in Year-5 
in the 12 schools, 484 were present on the recruitment day; 481 con-
sented whereas three declined without giving any specific reasons.
Six schools (245 children) were allocated to the intervention and 
six (236 children) to the control arm. All 12 schools were retained 
throughout the trial. Based on the baseline cotinine (indicative of SHS 
exposure), we expected to follow-up 450 children (229 in the interven-
tion and 221 in the control arm). However, 91% children (208/229) in 
the intervention and 88% (194/221) in the control arm completed their 
first follow-up at which the primary outcome was assessed. Similarly, 
95% (217/229) and 94% children (215/229) in the intervention and 
92% (203/221) and 91% children (201/221) in the control arm com-
pleted their 6-month and 12-month follow-ups, respectively.
Both arms were balanced on key sociodemographic and envir-
onmental characteristics (Table 1). The majority of children lived in 
homes with an outdoor space (average % per cluster 68) and used 
clean fuels for cooking (average % per cluster 94), but had no vis-
ible mould damage (average % per cluster 59) or kept any cattle 
(average % per cluster 78). However, there were baseline differences 
between the two arms on family smoking patterns, that is, living 
with a smoker and smoking restrictions at home (Tables 1 and 3).
Out of 450 children, 402 provided a salivary sample for coti-
nine, two months postallocation. At 2-month follow-up, mean sal-
ivary cotinine at the cluster level was 0.53 ng/ml (SD 0.36) in the 
intervention arm compared to 1.84 ng/ml (SD 1.49) in the control 
providing a mean difference of −1.31  ng/ml (95% CI  =  −2.86 to 
0.24) (Table 2). After adjusting for clustering, baseline cotinine, and 
other potential confounders, a similar mean difference of −1.54 ng/
ml (95% CI = −3.47 to 0.38) was estimated.
Table 3 and Supplementary Table 1 present a range of behavioral, 
clinical, and educational outcomes, respectively. No obvious differ-
ences between the intervention and the control arms were observed. 
Four-fifth of children in the intervention and three-fifth in the control 
arm reported complete smoking restrictions at home; little change 
was observed in both arms at the follow-ups. The average PEF per 
cluster remained a little below the predicted PEF (range = 83%–89%) 
in children in both trial arms at all timepoints. Almost all measures 
of educational attainment improved as the year progressed albeit in 
both arms. The proportion of children completing the respiratory 
symptom diary dropped from 70% and 72% in the first 2 months 
to 56% and 64% in the last 6 months in the intervention and the 
control arms, respectively (Supplementary Table  2). Most children 
(range  =  82%–92%) recorded respiratory symptoms that reached 
clinical threshold at least once during all three time periods. Children, 
who reported symptoms with a score above the clinical threshold, did 
so for nearly half of the number of weeks in the first 6 months and 
for one-third of the number of weeks in the last 6 months. Children 
and teachers reported no adverse events despite specific enquiries at 
the follow-ups.
Preliminary Economic Analysis
Costs for the training were 56 440 Bangladeshi taka (BDT) (equiva-
lent to £536) in Mirpur and 42 840 (£401) BDT at Savar giving a 
total of 99 280 BDT (£943). Based on the 245 children in the inter-
vention group the cost per child was 405.22 BDT (£3.85).
Based on two 45-min sessions and four 15-min refresher sessions, 
using a unit cost of 645.83 BDT per hour for teachers, the total inter-
vention cost for the six schools was 9687 BDT—39.5 BDT (£0.38) 
per child. Summing training costs and intervention cost to derive the 
total cost per child was estimated at 444.72 BDT (£4.22).
EQ-5D-Y was administered at baseline and three follow-up time-
points (Supplementary Table 3a). There is no single utility weight that 
can be applied to EQ-5D-Y hence we report percentages reporting no 
problems in any of the five dimensions. In the overall sample at base-
line, 53% reported no problems, compared with 59% at 2-month 
follow-up, 52% at 6-month follow-up, and 56% at 12-month 
follow-up. Complete EQ-5DY data (all items) and healthcare utiliza-
tion data were returned for all individuals. The results showed very 
low rates of contact with healthcare services (Supplementary Table 3b 
and c). Only the GP visit and prescription categories showed attend-
ance rates of above 5%. This suggests that collecting more detailed 
primary care and other parallel systems (pharmacies/traditional heal-
ers) utilization rates may be appropriate in a full RCT.
Discussion
Given that CLASS II was a pilot trial, we cannot interpret its find-
ings to make any definitive conclusions. However, the direction and 
magnitude of the effect size indicates that conducting a definitive 
trial to assess the effectiveness of SFI would be worthwhile. Our 
study provides key information to design and conduct such a trial in 
Bangladesh. We were able to recruit sufficient primary schools and 
retain all of them in the trial. Almost all children were eligible and 
able to participate; we were able to follow-up almost 90% children 
over a year. We were also able to assess primary and secondary out-
comes for most of the children.
SFI relies on children’s motivation and ability to persuade their 
families to change their smoking behavior by highlighting its ill 
effects. Therefore, SFI makes two sequential assumptions: school-
teachers can encourage children to negotiate changes in their fam-
ily’s smoking behavior, and this can motivate families to change. 
Often termed as “pester power,”25 the food and beverages industry 
have been using this to make families change their purchasing hab-
its, but it has been rarely used in health promotion. The recent 
reviews on intervention to protect children from SHS exposure13,26 
and to promote smoke-free homes15,27 did not include assessment of 
“pester power” to change family’s smoking behavior. The Cochrane 
reviews13,28 on the same topic included two school-based studies; 
one of which included schools that implemented smoke-free poli-
cies and asked children to persuade their families to do the same.29 
Further exploration is needed to assess the potential of this approach 
in other health promotion interventions.
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CLASS II trial had some limitations. Salivary cotinine only meas-
ures changes in children’s recent exposure to SHS. Moreover, we did 
not measure homes’ indoor air pollution levels—a future trial should 
include such measures. It is difficult to say if the difference observed 
in our study was a consequence of any smoking restrictions at home 
or due to other changes in smoking behaviors. Given that children 
were also exposed to SHS in places other than homes (Out of 95% 
children who were cotinine positive, only 44% lived with smokers), 
the change could be a reflection of children’s attempt to avoid places 
where people are visibly smoking. Although children were asked to 
report on smoking restrictions, self-reports in children are not vali-
dated and may not help in seeking explanations. Furthermore, we 
did not assess change in salivary cotinine at 6 and/or 12 months. 
We did not ask and exclude children on the basis of their smoke-
less tobacco use, which might have impacted our primary outcome 
of salivary cotinine. A future definitive trial should ask and exclude 
such children from the trial. Our intervention is complex and using 
several behavior change techniques; it would require a longitudinal 
evaluation to study processes/interactions—a consideration for fu-
ture studies. Although children did not report any adverse conse-
quences of negotiating smoking restrictions, it is possible that our 
intervention might have posed some difficulties for children. One po-
tential criticism of SFI is that it makes children—the victims and not 
the cause of SHS—responsible for stimulating behavior change in 
adults. This potential burden of responsibility and its consequences 
require careful exploration in process evaluations.
CLASS II trial included a range of outcomes based on children’s 
lung health and their academic performance—a major strength. 
However, it did not assess adult smoking cessation. Furthermore, it 
also did not investigate the effect of SFI on children’s smoking uptake 
rates. Both of these outcomes are plausible and could be included 
in a future trial. Our assessment of the frequency and severity of 
respiratory symptoms using a daily diary saw a downward trend 
in children’s response rate at subsequent follow-ups. This particular 
Figure 1. CLASS II Trial Flow Diagram (adapted from CONSORT 2010).
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assessment put children under a substantial research burden affect-
ing data completeness and its potential accuracy. In future trials, we 
suggest assessing respiratory symptoms at intervals, for example, 
the first week of each month.
Although the tools used for assessing self-reported measures in 
our trial have been used previously in children, we acknowledge that 
the translation of these tools to Bangla might have influenced their 
validity. Further psychometric analysis is, therefore, warranted to 
assess their validity in Bangla. Likewise, we collected demographic 
information from children but we did not validate these from other 
sources. In a future trial, we suggest validating these responses from 
their parents/carers. A future trial should also consider stratified ran-
domization using key behavioral variables (living with a smoker and 
smoking restrictions at home) to achieve a better balance across the 
trial arms than our pilot trial.
CLASS II is a pilot trial and therefore cannot make policy rec-
ommendations. However, its findings are highly relevant. It found 
that 95% of participating children were exposed to SHS. If true for 
other children in Bangladesh, this requires urgent and strong policy 
measures. The level of engagement shown by the schoolteachers and 
children was indicative of their willingness to take part in health 
promotion—relevant for delivering other public health measures 
through schools.
In summary, the CLASS  II trial was successful in recruiting, 
retaining, and randomizing primary schools and collecting useful 
outcomes data from their Year-5 pupils in Bangladesh. We have 
shown that conducting a definitive trial in future to assess the clin-
ical and cost-effectiveness of SFI is feasible and desirable.
Supplementary Material
Supplementary data are available at Nicotine & Tobacco Research 
online.
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Table 2. Estimates of the Primary Outcome (Saliva Cotinine) at 2 Months in Those Whose Saliva Cotinine Were Indicative of SHS Exposure 
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Intervention Control Mean difference
N Mean SD N Mean SD (95% CI) ICC
Salivary cotinine (at the individual level) 208 0.53 1.03 194 2.02 12.6 0 (0, 0.025)
Salivary cotinine (at the cluster level) 6 0.53 0.36 6 1.84 1.49 −1.31 (−2.86 to 0.24)
ρ
Salivary cotinine* −1.32 (−3.28 to 0.64)
Salivary cotinine** −0.82 (−2.68 to 1.03)
Salivary cotinine*** −1.33 (−3.25 to 0.59)
Salivary cotinine**** −1.54 (−3.47 to 0.38)
ρ using two-sample t-test adjusted for unequal variance at the cluster level.
*Adjusted for clustering using individual level data and taking into account minimization variables.
** Adjusted for clustering and baseline cotinine using individual level data and taking into account minimization variables.
*** Adjusted for clustering, baseline cotinine, outside space, parental education levels, and tobacco shops in the neighborhood using individual level data and 
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Table 3. Descriptive Statistics of the Behavioral and Clinical Outcomes at the Cluster Level at Baseline, 2-Month, 6-Month, and 12-Month 
Follow-ups
Intervention Control
Outcomes* Baseline 2 months 6 months 12 months Baseline 2 months 6 months 12 months
Number of children 229 209 217 215 221 194 203 201
Number of clusters 6 6 6 6 6 6 6 6
Smoking restrictions 
at home
Complete 0.84
(0.084)
0.74
(0.129)
0.76
(0.141)
0.88
(0.029)
0.61
(0.158)
0.61
(0.122)
0.73
(0.089)
0.61
(0.171)
Partial 0.03
(0.036)
0.09
(0.063)
0.10
(0.078)
0.04
(0.029)
0.06
(0.033)
0.10
(0.065)
0.11
(0.061)
0.15
(0.093)
None 0.13
(0.077)
0.17
(0.096)
0.14
(0.102)
0.07
(0.045)
0.34 (0.150) 0.29
(0.143)
0.16
(0.065)
0.24
(0.166)
Lung function Mean percentage of 
predicted PEF
88.3
(4.93)
89.1
(5.8)
85.8
(2.34)
83.7
(2.32)
85.8
(2.76)
88
(3.19)
83.2
(3.2)
85
(1.67)
Number of days 
absent (during the 
study period)
Mean 1.31
(0.257)
2.03
(1.2)
3.27
(0.34)
— 4.7
(6.9)
2.03
(1.2)
3.1
(0.377)
—
*Mean (SD) are reported at the cluster level.
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